Package 25021-317-40

{"route": ["INTRAVENOUS"], "spl_id": "02cc0ab9-5ab4-4016-9ec2-b96c4cb2be41", "openfda": {"unii": ["1GEV3BAW9J"], "rxcui": ["896771"], "spl_set_id": ["da8af6c2-d822-4ae5-9c2d-a1d161bdefd0"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-317-20)  / 20 mL in 1 VIAL", "package_ndc": "25021-317-20", "marketing_start_date": "20220901"}, {"sample": false, "description": "1 VIAL in 1 CARTON (25021-317-40)  / 40 mL in 1 VIAL", "package_ndc": "25021-317-40", "marketing_start_date": "20220901"}], "brand_name": "labetalol hydrochloride", "product_id": "25021-317_02cc0ab9-5ab4-4016-9ec2-b96c4cb2be41", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "25021-317", "generic_name": "labetalol hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "labetalol hydrochloride", "active_ingredients": [{"name": "LABETALOL HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "ANDA214533", "marketing_category": "ANDA", "marketing_start_date": "20220901", "listing_expiration_date": "20261231"}